Jakarta, June 30th, 2022 – PT Kalbe Farma Tbk (Kalbe) has received an award at the Bisnis Indonesia Corporate Social Responsibility Awards (BISRA) event of 2022, where it won the Gold Champion in Corporate Social Responsibility (CSR) in the listed company category.
“Kalbe is committed to conduct a sustainable initiative activity, especially in the field of health, with its theme, “Together We Heal the Nation”. Kalbe has also conducted several CSR programs, such as providing access to health services,” as stated by the Manager of Corporate Sustainability of Kalbe, Abi Nisaka.
Abi then added that this CSR award became a media to continuously improve the CSR activities that are designed and conducted by Kalbe Farma and its whole business units. Kalbe Farma also includes economic, environmental, social, and land surface temperature (LST) aspects, which are integrated into several company activities.
This year, BISRA had the theme of “Social Responsibility To Accelerate Stronger Recovery” and was attended by around 118 companies from several business lines. BISRA is an award given to business companies or organizations that have significant contributions to the development of the society, vulnerable communities, and the preservation of the environment in Indonesia.
As Abi explained, “This will be the second BISRA award for Kalbe, since we already received one in the platinum category.”
Abi emphasized that the sustainability growth would become the final achievement for all business companies or organizations. A successful company is not only categorized by its financial achievements, but also its success on balancing the business interests, the social welfare, and the preservation of the environment.
Regarding the award itself, there were several members on the board of jury that conducted evaluations for the 2022 BISRA award, including Vivi Yulasti, the Expert Staff of Social and Poverty Reduction of BAPPENAS, Susanto Samsudin, the National Director Habitat for Humanity Indonesia, and Maria Y. Benyamin, the Editor in Chief of Bisnis Indonesia.
Kalbe at a Glance
Founded in 1966, PT Kalbe Farma Tbk (Kalbe) is one of the largest open pharmaceutical companies in Southeast Asia. The company has four main divisions that engage in a portfolio of reliable and diversed brands, such as the prescription medicine division, the health product division which handles free medicines, multivitamins, and ready-to-drink supplement beverages, and the distribution and logistics divisions.
Kalbe has also developed a digital service ecosystem for the society, both in B2B with EMOS and in B2C with KlikDokter. EMOS is an order management application system that facilitates the distribution channels in commencing stock management or supply chain, while KlikDokter is a digital platform for health services, specifically telemedicine, which provides necessary health consultations and products for the society.
Now, Kalbe has more than 40 subsidiaries and 15 production facilities with international standards, employing around 16.000 employees who are being stationed in 76 branches all around Indonesia. Kalbe’s shares has been recorded in the Indonesia Stock Exchange (IDX) since 1991 (IDX:KLBF).